Ileana Andriola
Bari, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Real-world effectiveness and tolerability of desvenlafaxine in major depressive disorder: A multicentre prospective Italian national-cohort study.
Journal: Psychiatry research
Published: May 01, 2026
Effectiveness of repeated Esketamine nasal spray administration on anhedonic symptoms in treatment-resistant bipolar and unipolar depression: A secondary analysis from the REAL-ESK study group.
Journal: Psychiatry research
Published: June 11, 2025
Magnetoencephalographic Microstates Reveal Disrupted Brain Activity Patterns in Schizophrenia Controlling for Treatment-Related Modulations.
Journal: Schizophrenia bulletin
Published: May 29, 2025
Patient Experience with Intranasal Esketamine in Treatment-Resistant Depression: Insights from a Multicentric Italian Study (REAL-ESKperience).
Journal: Journal of personalized medicine
Published: March 06, 2025
Esketamine Treatment Trajectory of Patients with Treatment-Resistant Depression in the Mid and Long-Term Run: Data from REAL-ESK Study Group.
Journal: Current neuropharmacology
Published: May 16, 2024
Different abnormalities of mismatch negativity in schizophrenia and depression as assessed with magnetoencephalography.
Journal: Journal of psychiatric research
Published: March 22, 2024
Exploring vortioxetine combination with intranasal esketamine: A feasible alternative to SSRI/SNRI? - Insights from the REAL-ESK study.
Journal: Journal of affective disorders
Published: October 14, 2023
The rapid antidepressant effectiveness of repeated dose of intravenous ketamine and intranasal esketamine: A post-hoc analysis of pooled real-world data.
Journal: Journal of affective disorders
Published: September 14, 2023
Predicting outcome with Intranasal Esketamine treatment: A machine-learning, three-month study in Treatment-Resistant Depression (ESK-LEARNING).
Journal: Psychiatry research
Published: June 25, 2023
Investigating the Effectiveness and Tolerability of Intranasal Esketamine Among Older Adults With Treatment-Resistant Depression (TRD): A Post-hoc Analysis from the REAL-ESK Study Group.
Journal: The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry
Published: May 10, 2023
Esketamine in treatment-resistant depression patients comorbid with substance-use disorder: A viewpoint on its safety and effectiveness in a subsample of patients from the REAL-ESK study.
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: March 18, 2023
Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatment-resistant depression.
Journal: Bipolar disorders
Published: January 13, 2023
Last Updated: 09/26/2026